Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial
- PMID: 31574228
- DOI: 10.1164/rccm.201905-0968OC
Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial
Abstract
Rationale: A recent randomized controlled trial showed that a peripheral perfusion-guided resuscitation strategy was associated with lower mortality and less organ dysfunction when compared with lactate-guided resuscitation strategy in patients with septic shock, but the difference in the primary outcome, 28-day mortality, did not reach the proposed statistical significance threshold (P = 0.06). We tested different analytic methods to aid in the interpretation of these results.Objectives: To reassess the results of the ANDROMEDA-SHOCK trial using both Bayesian and frequentist frameworks.Methods: All patients recruited in ANDROMEDA-SHOCK were included. Both a post hoc Bayesian analysis and a mixed logistic regression analysis were performed. The Bayesian analysis included four different priors (optimistic, neutral, null, and pessimistic) for mortality endpoints. The probability of having a Sequential Organ Failure Assessment in the lowest quartile at 72 hours was assessed using Bayesian networks.Measurements and Main Results: In the Bayesian analysis, the posterior probability that a peripheral perfusion-targeted resuscitation strategy is superior to lactate-targeted resuscitation at 28 days was above 90% for all priors; the probability of benefit at 90 days was above 90% for all but the pessimistic prior. Using an optimistic prior, posterior median odds ratios were 0.61 (95% credible interval, 0.41-0.90) and 0.68 (95% credible interval, 0.47-1.01) for 28-day and 90-day mortality, respectively. The comparable frequentist odds ratios for 28-day and 90-day mortality were 0.61 (95% confidence interval [CI], 0.38-0.92) and 0.70 (95% CI, 0.45-1.08), respectively. The odds that that patients in the peripheral perfusion-targeted resuscitation arm had Sequential Organ Failure Assessment scores in the lower quartile at 72 hours was 1.55 (95% CI, 1.02-2.37).Conclusions: Peripheral perfusion-targeted resuscitation may result in lower mortality and faster resolution of organ dysfunction when compared with a lactate-targeted resuscitation strategy.
Keywords: Bayesian statistics; capillary refill time; lactate; septic shock.
Comment in
-
Bayesian Analysis in Critical Care Medicine.Am J Respir Crit Care Med. 2020 Feb 15;201(4):396-398. doi: 10.1164/rccm.201910-2019ED. Am J Respir Crit Care Med. 2020. PMID: 31899649 Free PMC article. No abstract available.
-
Interpretation or misinterpretation of clinical trials on septic shock: about the ANDROMEDA-SHOCK trial.Ann Transl Med. 2020 Jun;8(12):800. doi: 10.21037/atm.2020.01.29. Ann Transl Med. 2020. PMID: 32647725 Free PMC article. No abstract available.
-
When data interpretation should not rely on the magnitude of P values: the example of ANDROMEDA SHOCK trial.Ann Transl Med. 2020 Jun;8(12):802. doi: 10.21037/atm.2020.01.49. Ann Transl Med. 2020. PMID: 32647727 Free PMC article. No abstract available.
-
The Bayesian approach: may we learn a lesson from the ANDROMEDA-SHOCK trial?Ann Transl Med. 2020 Jun;8(12):804. doi: 10.21037/atm.2020.02.17. Ann Transl Med. 2020. PMID: 32647729 Free PMC article. No abstract available.
Similar articles
-
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071. JAMA. 2019. PMID: 30772908 Free PMC article. Clinical Trial.
-
Systematic assessment of fluid responsiveness during early septic shock resuscitation: secondary analysis of the ANDROMEDA-SHOCK trial.Crit Care. 2020 Jan 23;24(1):23. doi: 10.1186/s13054-020-2732-y. Crit Care. 2020. PMID: 31973735 Free PMC article.
-
Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol.Rev Bras Ter Intensiva. 2022 Jan-Mar;34(1):96-106. doi: 10.5935/0103-507X.20220004-pt. Rev Bras Ter Intensiva. 2022. PMID: 35766659 Free PMC article.
-
Towards the personalization of septic shock resuscitation: the fundamentals of ANDROMEDA-SHOCK-2 trial.Rev Esp Anestesiol Reanim (Engl Ed). 2024 Feb;71(2):112-124. doi: 10.1016/j.redare.2024.01.003. Epub 2024 Jan 18. Rev Esp Anestesiol Reanim (Engl Ed). 2024. PMID: 38244774 Review.
-
Is There an Optimum Duration of Fluid Bolus in Pediatric Septic Shock? A Critical Appraisal of "Fluid Bolus Over 15-20 Versus 5-10 Minutes Each in the First Hour of Resuscitation in Children With Septic Shock: A Randomized Controlled Trial" by Sankar et al (Pediatr Crit Care Med 2017; 18:e435-e445).Pediatr Crit Care Med. 2018 Apr;19(4):369-371. doi: 10.1097/PCC.0000000000001459. Pediatr Crit Care Med. 2018. PMID: 29369077 Review.
Cited by
-
Can Peripheral Skin Perfusion Be Used to Assess Organ Perfusion and Guide Resuscitation Interventions?Front Med (Lausanne). 2020 Jun 23;7:291. doi: 10.3389/fmed.2020.00291. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32656220 Free PMC article. Review.
-
Quality of evidence supporting Surviving Sepsis Campaign Recommendations.Anaesth Crit Care Pain Med. 2020 Aug;39(4):497-502. doi: 10.1016/j.accpm.2020.06.015. Epub 2020 Jul 7. Anaesth Crit Care Pain Med. 2020. PMID: 32650126 Free PMC article.
-
Can plethysmographic capillary refill time predict lactate during sepsis? An observational study from Morocco.Afr J Emerg Med. 2024 Sep;14(3):167-171. doi: 10.1016/j.afjem.2024.06.007. Epub 2024 Jun 28. Afr J Emerg Med. 2024. PMID: 39040945 Free PMC article.
-
Emerging concepts in the care of patients with cirrhosis and septic shock.World J Hepatol. 2023 Apr 27;15(4):497-514. doi: 10.4254/wjh.v15.i4.497. World J Hepatol. 2023. PMID: 37206653 Free PMC article. Review.
-
Using Bayesian Hypothesis-testing to Reanalyze Randomized Controlled Trials: Does it Always Tell the Truth, the Whole Truth and Nothing but the Truth?Indian J Crit Care Med. 2024 Nov;28(11):1005-1008. doi: 10.5005/jp-journals-10071-24833. Epub 2024 Oct 30. Indian J Crit Care Med. 2024. PMID: 39882061 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical